Skip to content

Optical Blood Pressure Monitoring Via Mobile Application, 3 Arms Swiss Clinical Study

Arm 1: Optical Blood Pressure Monitoring (OptiBP Mobile App), An Accurate Blood Pressure Measurement Compared to Invasive Blood Pressure Measurement. Arm 2 and Arm 3: Improvement and Validation of the Smartphone Blood Pressure Measurement (OptiBP Mobile App). A Prospective, Method Comparison, Proof of Concept Study in a Swiss Population.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03875248
Acronym
OPTIBP
Enrollment
350
Registered
2019-03-14
Start date
2019-03-18
Completion date
2021-06-14
Last updated
2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Brief summary

Validation of an existing algorithm designed to estimate blood pressure based on collected optical signals on patients against two reference methods, which are the arterial catheter (arm 1) and the ausculatory sphygmomanometer (arm 2).

Detailed description

The purpose of the study is to compare the blood pressure values measured by a mobile application used with a smartphone and the values measured by reference equipments, which are the arterial line and the ausculatory sphygmomanometer . In the arm 1 of the study, patients scheduled for general anesthesia at the Centre Hospitalier Universitaire Vaudois (CHUV) and at the Hôpitaux Universitaire de Genève (HUG) will be recruited and their pressure will be measured with both mesurement methods. General anesthesia is known to generate significant variations in blood pressure at the time of induction. During the first minutes of anesthesia, the patient's blood pressure will be measured in parallel with the mobile application and with the reference equipment. After the intervention, the values obtained by the two methods will be compared to confirm the reliability of the data obtained with the mobile application. In the arm 2, patients scheduled for a medical appointment at the hypertension unit of the Centre Hospitalier Universitaire Vaudois (CHUV) will be recruited. Their pressure will be measured with the mobile application and with the reference equipment at various time points. After the intervention, the values obtained by the two methods will be compared to confirm the reliability of the data obtained with the mobile application. In the arm 3, patients scheduled for a medical appointment at the maternity unit of the Centre Hospitalier Universitaire Vaudois (CHUV) will be recruited. Their pressure will be measured with the mobile application and with the reference equipment at various time points. After the intervention, the values obtained by the two methods will be compared to confirm the reliability of the data obtained with the mobile application.

Interventions

DEVICEBlood pressure measurement

Measure optically the blood pressure through the use of a smartphone

Sponsors

CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
CollaboratorINDUSTRY
Biospectal
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

The arm 1 of the study has been designed as a multicentric prospective pilot study. The arm 2 of the study has been designed as a monocentric prospective pilot study. The arm 3 of the study has been designed as a monocentric prospective pilot study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Arm 1, Inclusion Criteria: * Informed Consent as documented by signature * Men or women older than 18 years old * Good understanding of written and oral speaking used at the centre where the study will be carried out * American Society of Anesthesiology clinical classification Risk (ASA) Class 1-3 * Scheduled for a general anesthesia * Necessitating an arterial catheters for the anesthesia and surgery. Arm 1,

Exclusion criteria

* Patients that cannot sign informed consent * Patients in emergency situation, are not legally competent, cannot understand the situation * ASA Risk class 4 * Dyshythmia like bigeminy, trigeminy, isolated Ventricular Premature Beats (VPB), atrial fibrillation * Lesion or deficiency on hand, preventing index obstruction of smartphone's camera * Known contact dermatitis to nickel/chromium Arm 2, Inclusion Criteria: * Informed Consent as documented by signature * Men or women older than 18 years old * Good understanding of written and oral speaking used at the centre where the study will be carried out Arm 2,

Design outcomes

Primary

MeasureTime frameDescription
Confirmation of measurement done with the investigational deviceFirst 20 minutesArm 1: Comparision of values to invasive reference method (arterial line)

Secondary

MeasureTime frameDescription
Usability assessmentFirst 20 minutesIdentification of possible use error in the manipulation of the device and in the performance of the measure
Safety of procedure by assessing inconvenience and adverse eventsFirst 20 minutesSafety by assessing inconvenience and adverse events.

Countries

Switzerland

Contacts

Primary ContactPatrick Schoettker
Patrick.Schoettker@chuv.ch‭+41 79 556 10 43

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026